GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Median PS Value

Remus Pharmaceuticals (NSE:REMUS) Median PS Value : ₹0.00 (As of Mar. 27, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Remus Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹774.016. Remus Pharmaceuticals's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ₹0.00.

As of today (2025-03-27), Remus Pharmaceuticals's share price is ₹2242.60. Remus Pharmaceuticals's Median PS Value is ₹0.00. Therefore, Remus Pharmaceuticals's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Remus Pharmaceuticals's Median PS Value or its related term are showing as below:

NSE:REMUS's Price-to-Median-PS-Value is not ranked *
in the Medical Distribution industry.
Industry Median: 0.85
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Remus Pharmaceuticals Median PS Value Historical Data

The historical data trend for Remus Pharmaceuticals's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Median PS Value Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
Median PS Value
- - - -

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
Median PS Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Remus Pharmaceuticals's Median PS Value

For the Medical Distribution subindustry, Remus Pharmaceuticals's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remus Pharmaceuticals's Price-to-Median-PS-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's Price-to-Median-PS-Value falls into.


;
;

Remus Pharmaceuticals Median PS Value Calculation

Remus Pharmaceuticals's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=774.016*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Remus Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹774.016.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remus Pharmaceuticals  (NSE:REMUS) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Remus Pharmaceuticals's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=2242.60/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remus Pharmaceuticals Median PS Value Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Remus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines